Andrew W. McCaskie

Andrew W. McCaskie

Auto-generated profile, based on publicly available information

Andrew W. McCaskie

Department of Surgery, University of Cambridge , Cambridge, CB2 0QQ

Research Focus & Metrics

Academic Career Length

37Years (1990-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2012 in The Lancet
Verified
Journal Article
Open access
EZEleftheria Zeggini
Eleftheria Zeggini
KPKalliope Panoutsopoulou
Kalliope Panoutsopoulou
LSLorraine Southam
Lorraine Southam
NRNigel W. Rayner
Nigel W. Rayner
ADAaron G. Day-Williams
Aaron G. Day-Williams
JLJohn Loughlin
John Loughlin
Osteoarthritis is the most common form of arthritis worldwide and is a major cause of pain and disability in elderly people. The health economic burden of osteoarthritis is increasing commensurate with obesity prevalence and longevity. Osteoarthritis has a strong genetic component but the success of previous genetic studies has been restricted due to insufficient sample sizes and phenotype heterogeneity. We undertook a large genome-wide association study (GWAS) in 7410 unrelated and retrospectively and prospectively selected patients with severe osteoarthritis in the arcOGEN study, 80% of whom had undergone total joint replacement, and 11,009 unrelated controls from the UK. We replicated the most promising signals in an independent set of up to 7473 cases and 42,938 controls, from studies in Iceland, Estonia, the Netherlands, and the UK. All patients and controls were of European descent. We identified five genome-wide significant loci (binomial test p≤5·0×10(-8)) for association with osteoarthritis and three loci just below this threshold. The strongest association was on chromosome 3 with rs6976 (odds ratio 1·12 [95% CI 1·08-1·16]; p=7·24×10(-11)), which is in perfect linkage disequilibrium with rs11177. This SNP encodes a missense polymorphism within the nucleostemin-encoding gene GNL3. Levels of nucleostemin were raised in chondrocytes from patients with osteoarthritis in functional studies. Other significant loci were on chromosome 9 close to ASTN2, chromosome 6 between FILIP1 and SENP6, chromosome 12 close to KLHDC5 and PTHLH, and in another region of chromosome 12 close to CHST11. One of the signals close to genome-wide significance was within the FTO gene, which is involved in regulation of bodyweight-a strong risk factor for osteoarthritis. All risk variants were common in frequency and exerted small effects. Our findings provide insight into the genetics of arthritis and identify new pathways that might be amenable to future therapeutic intervention. arcOGEN was funded by a special purpose grant from Arthritis Research UK.

20 March 2018 in Nature Genetics
Verified
Journal Article
Closed access
PDF file
EZEleni Zengini
Eleni Zengini
KHKonstantinos Hatzikotoulas
Konstantinos Hatzikotoulas
ITIoanna Tachmazidou
Ioanna Tachmazidou
JSJulia Steinberg
Julia Steinberg
FHFernando Pires Hartwig
Fernando Pires Hartwig
EZEleftheria Zeggini
Eleftheria Zeggini

1 February 2011 in Annals of the Rheumatic Diseases
Verified
Journal Article
Closed access
PDF file
EEEvangelos Evangelou
Evangelos Evangelou
Ana M ValdesAna M Valdes
Ana M Valdes
HKHanneke J M Kerkhof
Hanneke J M Kerkhof
USUnnur Styrkarsdottir
Unnur Styrkarsdottir
YZYanYan Zhu
YanYan Zhu
TSTimothy D Spector
Timothy D Spector
Objectives Osteoarthritis (OA) is the most prevalent form of arthritis and accounts for substantial morbidity and disability, particularly in older people. It is characterised by changes in joint structure, including degeneration of the articular cartilage, and its aetiology is multifactorial with a strong postulated genetic component. Methods A meta-analysis was performed of four genome-wide association (GWA) studies of 2371 cases of knee OA and 35 909 controls in Caucasian populations. Replication of the top hits was attempted with data from 10 additional replication datasets. Results With a cumulative sample size of 6709 cases and 44 439 controls, one genome-wide significant locus was identified on chromosome 7q22 for knee OA (rs4730250, p=9.2×10−9), thereby confirming its role as a susceptibility locus for OA. Conclusion The associated signal is located within a large (500 kb) linkage disequilibrium block that contains six genes: PRKAR2B (protein kinase, cAMP-dependent, regulatory, type II, β), HPB1 (HMG-box transcription factor 1), COG5 (component of oligomeric golgi complex 5), GPR22 (G protein-coupled receptor 22), DUS4L (dihydrouridine synthase 4-like) and BCAP29 (B cell receptor-associated protein 29). Gene expression analyses of the (six) genes in primary cells derived from different joint tissues confirmed expression of all the genes in the joint environment.

1 September 2018 in Osteoarthritis and Cartilage
Verified
Journal Article
Closed access
JMJ.W. MacKay
J.W. MacKay
SLS.B.L. Low
S.B.L. Low
Toby SmithToby Smith
Toby Smith
ATA.P. Toms
A.P. Toms
AMA.W. McCaskie
A.W. McCaskie
FGF.J. Gilbert
F.J. Gilbert

1 September 2011 in The American Journal of Human Genetics
Verified
Journal Article
Open access
ADAaron G. Day-Williams
Aaron G. Day-Williams
LSLorraine Southam
Lorraine Southam
KPKalliope Panoutsopoulou
Kalliope Panoutsopoulou
NRNigel W. Rayner
Nigel W. Rayner
TETõnu Esko
Tõnu Esko
EZEleftheria Zeggini
Eleftheria Zeggini
Osteoarthritis (OA) is a prevalent, heritable degenerative joint disease with a substantial public health impact. We used a 1000-Genomes-Project-based imputation in a genome-wide association scan for osteoarthritis (3177 OA cases and 4894 controls) to detect a previously unidentified risk locus. We discovered a small disease-associated set of variants on chromosome 13. Through large-scale replication, we establish a robust association with SNPs in MCF2L (rs11842874, combined odds ratio [95% confidence interval] 1.17 [1.11-1.23], p = 2.1 × 10(-8)) across a total of 19,041 OA cases and 24,504 controls of European descent. This risk locus represents the third established signal for OA overall. MCF2L regulates a nerve growth factor (NGF), and treatment with a humanized monoclonal antibody against NGF is associated with reduction in pain and improvement in function for knee OA patients.

21 August 2017 in Scientific Reports
Verified
Journal Article
Open access
PDF file
JSJulia Steinberg
Julia Steinberg
GRGraham R. S. Ritchie
Graham R. S. Ritchie
TRTheodoros I. Roumeliotis
Theodoros I. Roumeliotis
RJRaveen L. Jayasuriya
Raveen L. Jayasuriya
MCMatthew James Robert Clark
Matthew James Robert Clark
EZEleftheria Zeggini
Eleftheria Zeggini
Osteoarthritis (OA) is a common disease characterized by cartilage degeneration and joint remodeling. The underlying molecular changes underpinning disease progression are incompletely understood. We investigated genes and pathways that mark OA progression in isolated primary chondrocytes taken from paired intact versus degraded articular cartilage samples across 38 patients undergoing joint replacement surgery (discovery cohort: 12 knee OA, replication cohorts: 17 knee OA, 9 hip OA patients). We combined genome-wide DNA methylation, RNA sequencing, and quantitative proteomics data. We identified 49 genes differentially regulated between intact and degraded cartilage in at least two –omics levels, 16 of which have not previously been implicated in OA progression. Integrated pathway analysis implicated the involvement of extracellular matrix degradation, collagen catabolism and angiogenesis in disease progression. Using independent replication datasets, we showed that the direction of change is consistent for over 90% of differentially expressed genes and differentially methylated CpG probes. AQP1, COL1A1 and CLEC3B were significantly differentially regulated across all three –omics levels, confirming their differential expression in human disease. Through integration of genome-wide methylation, gene and protein expression data in human primary chondrocytes, we identified consistent molecular players in OA progression that replicated across independent datasets and that have translational potential.